WuXi AppTec HitS News and Activities

WuXi AppTec HitS is owned by HiberCell. HiberCell has a direct presence in 2 countries.

HiberCell has 7 subsidiaries including Genuity Science, STA Pharmaceutical and WuXi AppTec.

They are in:

• Biotechnology88%
• Pharmaceuticals13%

View the org chart displaying its 5 main executives

Most searched biographies at WuXi AppTec HitS

• Alex Satz, Senior Director, Head of Europe and Head of Chemistry
• Moran Jerabek-Willemsen, Head of Biophysics & Screening
• Wenji Su, Senior Director and Head of China, Head of China R&D

Create your alert
to follow the executive moves at WuXi AppTec HitS.

HiberCell has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Archimed Group has acquired Esperion Therapeutics (posted on July 14 2026).
• The new name of ChemoTech is Neem’s Hill. (posted on July 14 2026).
• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by WuXi AppTec HitS

Social media about WuXi AppTec HitS

• WuXi AppTec HitS on Wikipedia, Google News & Yahoo Finance
• WuXi AppTec HitS on LinkedIn, X (Twitter) & YouTube